Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119905812 | 11990581 | 2 | F | 20130807 | 20160706 | 20160202 | 20160720 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL000134 | VALIDUS | 0.00 | Y | 0.00000 | 20160720 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119905812 | 11990581 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 75 MG, BID | Y | 17963 | 75 | MG | ||||||||
| 119905812 | 11990581 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EVERY 6 WEEKS | U | 0 | 20 | MG | |||||||
| 119905812 | 11990581 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EVERY 8 WEEKS | U | 0 | 20 | MG | |||||||
| 119905812 | 11990581 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 119905812 | 11990581 | 5 | C | POTASSIUM | POTASSIUM | 1 | UNK | U | 0 | ||||||||||
| 119905812 | 11990581 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 119905812 | 11990581 | 7 | C | MONOPRIL | FOSINOPRIL SODIUM | 1 | UNK | U | 0 | ||||||||||
| 119905812 | 11990581 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | U | 0 | ||||||||||
| 119905812 | 11990581 | 9 | C | ASA | ASPIRIN | 1 | UNK | U | 0 | COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119905812 | 11990581 | 1 | Atrial fibrillation |
| 119905812 | 11990581 | 2 | Insulinoma |
| 119905812 | 11990581 | 4 | Product used for unknown indication |
| 119905812 | 11990581 | 5 | Product used for unknown indication |
| 119905812 | 11990581 | 6 | Product used for unknown indication |
| 119905812 | 11990581 | 7 | Product used for unknown indication |
| 119905812 | 11990581 | 8 | Product used for unknown indication |
| 119905812 | 11990581 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119905812 | 11990581 | OT |
| 119905812 | 11990581 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119905812 | 11990581 | Atrial fibrillation | |
| 119905812 | 11990581 | Blindness | |
| 119905812 | 11990581 | Blood glucose increased | |
| 119905812 | 11990581 | Blood pressure increased | |
| 119905812 | 11990581 | Blood pressure systolic increased | |
| 119905812 | 11990581 | Body temperature decreased | |
| 119905812 | 11990581 | Dehydration | |
| 119905812 | 11990581 | Dyspnoea | |
| 119905812 | 11990581 | Feeling abnormal | |
| 119905812 | 11990581 | Heart rate decreased | |
| 119905812 | 11990581 | Heart rate irregular | |
| 119905812 | 11990581 | Inappropriate schedule of drug administration | |
| 119905812 | 11990581 | Osteoarthritis | |
| 119905812 | 11990581 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119905812 | 11990581 | 1 | 201512 | 0 | ||
| 119905812 | 11990581 | 2 | 20051005 | 0 |